Fluoride treatment to prevent tooth decay in NPC patients
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests whether applying sodium fluoride to teeth can prevent cavities during radiation therapy for nasopharyngeal cancer. It is for patients with stage II-IVa NPC who are about to start radiotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have nasopharyngeal cancer (NPC) confirmed by biopsy, type II or III.
- Your cancer stage is II, III, or IVa (not stage I or IVb).
- You are between 18 and 60 years old.
- You have no distant spread (metastasis) of cancer.
- You have at least 2 functional teeth in each of the 6 sections of your mouth.
- You have good blood counts and normal liver and kidney function.
- You are not pregnant and agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a custom-fitted dental stent (like a mouthguard) can help protect your sense of taste during radiation and chemotherapy for nasopharyngeal cancer. If you qualify, you'll receive either standard care or the stent, and your taste changes will be tracked.
This trial tests a shorter course of radiation therapy for people with nasopharyngeal cancer, a type of head and neck cancer. The goal is to see if a hypofractionated (fewer, larger doses) approach is safe and effective.
This trial tests a new way to shape the radiation field for nasopharyngeal cancer that has spread into the nasal cavity. The goal is to reduce radiation to the nose while still effectively treating the cancer.
This study looks at how the immune system responds to radiation therapy for nasopharyngeal cancer. It will use scans and blood tests to find markers that might predict how well treatment works.
This trial tests whether a personalized radiation plan for the neck can prevent cancer from spreading in people with nasopharyngeal carcinoma. It's for those whose cancer hasn't spread beyond the head and neck area.
This trial tests whether a targeted radiation therapy, combined with the immunotherapy drug toripalimab before and after treatment, can reduce side effects while still effectively treating nasopharyngeal cancer. It is for patients with certain tumor sizes or stages who have not had prior neck radiation or immunotherapy.
Hear when a new Sodium Fluoride trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.